SCQM注册中轴型银屑病关节炎与伴银屑病中轴型脊柱关节炎患者的特征比较
在瑞士临床质量管理注册中,比较中轴型脊柱关节炎(axSpA)尤其伴银屑病者与中轴型银屑病关节炎(axial PsA)患者的特征。axial PsA较axSpA+pso起病及入组年龄更大、HLA-B27阳性更少、背痛更少、指趾炎和外周关节炎更多,疾病活动度、功能与活动度相当。
要点
- axSpA患者中既往或当前银屑病为479/4489例(10.7%)。
- PsA患者中中轴受累(按治疗风湿科医生意见)为1153/2631例(43.8%)。
- axial PsA与axSpA+pso疾病活动度、功能及活动度可比。
核心结论
- 中轴型银屑病关节炎与伴银屑病的中轴型脊柱关节炎在重要人口学和临床特征及遗传学上存在差异,但疾病负担相当。
- 作者认为专门针对中轴型银屑病关节炎的治疗研究似乎有必要。
研究设计与样本
- 纳入瑞士临床质量管理(SCQM)注册中具有银屑病和中轴受累信息的axSpA和PsA患者。
- axSpA患者按是否伴银屑病分层(axSpA±pso),PsA患者按中轴型或严格外周型分层。
主要发现
- axSpA患者中既往或当前银屑病为479/4489例(10.7%)。
- PsA患者中中轴受累(按治疗风湿科医生意见)为1153/2631例(43.8%)。
- 与axSpA+pso相比,axial PsA患者起病年龄和入组SCQM年龄更大,HLA-B27阳性更少,背痛更少,指趾炎和外周关节炎患病率更高。
- axial PsA中银屑病或PsA家族史阳性更常见,而axSpA+pso中axSpA家族史阳性更常见。
- axSpA+pso与axial PsA的疾病活动度、功能和活动度可比。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Within the spectrum of spondyloarthritides, axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) present with overlapping features. Axial involvement in PsA (axial PsA) is treated according to recommendations for axSpA, as specific studies in axial PsA are scarce. We compared characteristics of patients with axSpA (particularly of patients with axSpA and concomitant psoriasis (pso)) with those of patients with axial PsA. METHODS: Patients with axSpA and PsA in the Swiss Clinical Quality Management (SCQM) registry were included if information on pso and axial involvement was available. Patients with AxSpA were stratified by axSpA with and without pso (axSpA±pso) and patients with PsA were stratified to axial PsA or strictly peripheral PsA. RESULTS: Previous or current psoriasis was observed in 479/4489 patients with axSpA (10.7%). Of 2631 patients with PsA, 1153 (43.8%) presented with axial involvement (opinion of the treating rheumatologist). Compared with patients with axSpA+pso, patients with axial PsA were older at symptom onset and at inclusion in SCQM, were less frequently HLA-B27 positive, had back pain less frequently and a higher prevalence of dactylitis and peripheral arthritis. A positive family history of pso or PsA was more frequent in axial PsA, while a positive family history of axSpA was more frequent in patients with axSpA+pso. Disease activity, function and mobility were comparable in axSpA+pso versus axial PsA. CONCLUSION: Patients with axial PsA differ from patients with axSpA+pso in important demographic and clinical characteristics, and genetically, but present with a comparable disease burden. Treatment studies specifically dedicated to axial PsA seem warranted.
引用
- Ciurea A, Götschi A, Kissling S, et al. Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry. RMD Open. 2023. PMID: 37277211. doi:10.1136/rmdopen-2022-002956
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。